搜索临床试验以:GORE® EXCLUDER® 髂支内假体
总计213个结果
-
Medtronic Spinal and BiologicsAverion International Corporation; Baim Institute for Clinical Research撤销下颌牙槽骨丢失 | 下颌骨无牙槽嵴
-
St. Jude Children's Research HospitalPfizer终止
-
University of Texas Southwestern Medical Center邀请报名
-
ESM Technologies, LLCQPS Bio-Kinetic; KD Pharma Group完全的
-
Nabiqasim Industries (Pvt) LtdDow University of Health Sciences未知
-
Latin American Cooperative Oncology GroupPfizer完全的
-
Soonchunhyang University HospitalStanford University; Korea University Anam Hospital; Hanyang University; Severance Hospital; Wonju... 和其他合作者未知
-
Hôpital Européen MarseilleAssistance Publique Hopitaux De Marseille完全的
-
Cerenovus, Part of DePuy Synthes Products, Inc.招聘中
-
Erasme University HospitalUniversity of Liege; Bone Therapeutics S.A完全的
-
University of OuluTurku University Hospital; Oulu University Hospital; Tampere University Hospital; Skane University...完全的
-
W.L.Gore & Associates终止
-
ESM Technologies, LLCQPS Bio-Kinetic完全的
-
Phytopharm Consulting BrazilFederal University of Health Science of Porto Alegre; Herbarium Laboratorio Botanico Ltda未知
-
H. Lee Moffitt Cancer Center and Research Institute终止
-
University Hospital, GhentAmsterdam UMC, location VUmc; University Ghent完全的
-
Sygehus LillebaeltCeraPedics, Inc未知
-
Institut de Médecine et d'Epidémiologie Appliquée...Gilead Sciences; Roche Pharma AG; ANRS, Emerging Infectious Diseases; BioMérieux; Mairie de Paris完全的
-
University of North Carolina, Chapel HillColgate Palmolive终止
-
University Hospital, GrenobleUniversité Joseph Fourier; Centre National de la Recherche Scientifique, France完全的
-
Abbott Medical Devices完全的
-
Rennes University HospitalÉcole Normale Supérieure de Cachan完全的
-
Oslo University HospitalKarolinska University Hospital; Tine完全的
-
Wyeth is now a wholly owned subsidiary of Pfizer完全的移植物排斥 | 肾功能衰竭美国, 西班牙, 加拿大, 瑞士, 奥地利, 澳大利亚, 新西兰
-
AIO-Studien-gGmbHNovartis Pharmaceuticals; Assign Data Management and Biostatistics GmbH完全的神经内分泌癌,3 级 | 低分化恶性神经内分泌癌 | 转为 G3 的 1 级神经内分泌癌 [分化良好的神经内分泌癌] | 转为 G3 的 2 级神经内分泌癌 [中度分化神经内分泌癌] | 神经内分泌肿瘤,3 级和疾病进展,根据实体瘤反应评估标准 (RECIST 1.1.) 衡量德国